Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-06-09

FDA Approved: PREGABALIN — Supplemental Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved a supplemental application for a generic pregabalin from Rising Pharma Holdings, Inc., authorizing its marketing for the same indications as the br…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pregabalin (Pregabalin)

Snippet

SUPPL AP for PREGABALIN (PREGABALIN)